Skip to main content

Table 1 Genetic description and clinical data of family with dominant calcium-sensing receptor (CaSR) variant

From: Sequencing the CaSR locus in Pakistani stone formers reveals a novel loss-of-function variant atypically associated with nephrolithiasis

Family ID/individuals

Age of onset (years)

NL Episodes

Stone composition (age at stone retrieval in years)

Variant genomic change

Total allele frequency in ExAC, gnomAD v2.1.1, gnomAD v3.1.1 databases (H, het, total)

Canonical transcript NM_000388 Predicted Effect

Alternative transcript NM_001178065 predicted effect

KS72

       

 II 3

18

2

CaOxMo 56%, CaOxDi 41%, Struvite 3% (18)

GRCh37

Chr3:122000958A>G

Absent

c.1609-2A>G

c.1637A>G

    

GRCh38

Chr3:12228211A>G

 

Splice Site Effect (MaxEnt -100%, NNSPLICE -100%, SSF -100%)

p.Gln546Arg (SIFT Tol 0.27; MT Del; PP2 Ben 0.032

 II 4

19

2

CaOxMo 55%, CaOxDi 40%, Struvite 5% (19)

    
  1. CaOxMo Calcium oxalate monohydrate, CaOxDi Calcium oxalate dehydrate, ID identification code, H Homozygous subjects, het Heterozygous subjects, MaxEnt Maximum entropy splice site scoring software, MT “MutationTaster” prediction score, NL nephrolithiasis, NNSSPLICE Splice site prediction by neural network software, PP2 PolyPhen-2 prediction score, SIFT “Sorting Tolerant From Intolerant” prediction score, SSF splice site finder software, total total alleles
  2. This variant was submitted from an independent case to ClinVar (RCV001059152.1) during the current study